{"organizations": [], "uuid": "d93de292a22f2f2a1e2b3c5b3e0fa5b3c742c71e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-angiodynamics-receives-fda-expedit/brief-angiodynamics-receives-fda-expedited-access-pathway-designation-for-nanoknife-system-for-treatment-of-stage-iii-pancreatic-cancer-idUSFWN1PJ19Q", "country": "US", "domain_rank": 408, "title": "BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-24T23:17:00.000+02:00", "replies_count": 0, "uuid": "d93de292a22f2f2a1e2b3c5b3e0fa5b3c742c71e"}, "author": "", "url": "https://www.reuters.com/article/brief-angiodynamics-receives-fda-expedit/brief-angiodynamics-receives-fda-expedited-access-pathway-designation-for-nanoknife-system-for-treatment-of-stage-iii-pancreatic-cancer-idUSFWN1PJ19Q", "ord_in_thread": 0, "title": "BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer", "locations": [], "entities": {"persons": [{"name": "nano", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "angiodynamics inc", "sentiment": "none"}, {"name": "angiodynamics inc", "sentiment": "none"}, {"name": "angiodynamics", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "treatment of stage iii pancreatic cancer reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 19 PM / in 6 minutes BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer Reuters Staff 1 Min Read \nJan 24 (Reuters) - Angiodynamics Inc: \n* ANGIODYNAMICS RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE NANOKNIFE® SYSTEM FOR THE TREATMENT OF STAGE III PANCREATIC CANCER \n* ANGIODYNAMICS INC - ‍FDA GRANTED EXPEDITED ACCESS PATHWAY DESIGNATION TO COMPANY‘S NANOKNIFE SYSTEM​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-24T23:17:00.000+02:00", "crawled": "2018-01-24T23:29:03.030+02:00", "highlightTitle": ""}